BV

CircuLite is developing disruptive solutions to improve the treatment of chronic heart failure. The Company’s minimally invasive circulatory support systems are intended to work in conjunction with the heart to enhance clinical outcomes and improve quality of life for patients and their families. Synergy®, currently in a CE Mark clinical trial, features the world’s smallest surgically implanted blood pump for long-term use in patients diagnosed with heart failure. Next-generation circulatory support systems in development that incorporate CircuLite’s micro-pump technology include an endovascular system, a right-heart system, and a pediatric system. For more information, visit our website at www.circulite.com.

Company’s Keywords:

healthcare, startup medical device developer & circulatory support